Consistent with the small molecule screening data, strong combinatorial activity and induction of programmed cell death were confirmed for PAK1 and IAP dual inhibition with EBC-1 and additional NSCLC cell lines. Here, PAK1 is linked to non-small cell lung carcinoma.